Explores KeraSkin™ for skin corrosion testing, indicating its potential in chemical safety assessment.
Skin corrosion and irritation are critical local toxicological endpoints associated with chemical exposure. OECD has approved the use of the Reconstructed Human Epidermis (RhE) model, KeraSkin™, as me-too in vitro skin irritation test of OECD Test Guideline (TG) 439. Here, we explored the applicability of KeraSkin™ as a me-too test method for in vitro skin corrosion test OECD TG 431, to expand its validated use beyond skin irritation test. Thirty reference chemicals, including Category 1A, 1B/1C, and non-corrosive substances as described in OECD TG 431 performance standards (PS), were tested. Test chemicals were applied for 3 or 60 min, and cell viability (CV) was measured using MTT assay. Classification criteria were based on viability thresholds, wherein <15% at 3 min indicates Category 1A corrosives, ≥15% at 3 min and <15% at 60 min, Category 1B/1C, and ≥50% at 3 min and ≥15% at 60 min indicates non-corrosives. The KeraSkin™ skin corrosion test demonstrated reliable predictive capacity with 100% sensitivity, 70% specificity, 90% accuracy (corrosive/non-corrosive), and 76.7% sub-category accuracy in the predictive capacity assessment using 30 chemicals, which satisfies the accuracy criteria of OECD TG 431 PS. Collectively, we demonstrated that KeraSkin™ can be a reliable in vitro model for skin corrosion test, expanding the availability of validated non-animal methods for global chemical safety assessment. Further full validation test is underway for the approval of the KeraSkin™ skin corrosion test for a me-too test method of OECD TG 431.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: